About Paragonix Technologies
Paragonix Technologies is a company based in Boston (United States) founded in 2010 was acquired by Getinge in August 2024.. Paragonix Technologies has raised $25.1 million across 4 funding rounds from investors including Getinge, HHS and Signet Healthcare Partners. Paragonix Technologies offers products and services including SherpaPak Cardiac Preservation, LUNGguard Organ Preservation, BAROguard Lung Preservation, KidneyVault Renal Perfusion, and Paragonix App. Paragonix Technologies operates in a competitive market with competitors including TransMedics, OrganOx, Bridge to Life, Vascular Perfusion and ADVITOS, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Paragonix Technologies, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Paragonix Technologies
Paragonix Technologies offers a comprehensive portfolio of products and services, including SherpaPak Cardiac Preservation, LUNGguard Organ Preservation, BAROguard Lung Preservation, KidneyVault Renal Perfusion, and Paragonix App. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Preserves hearts during transport with controlled temperatures
Maintains optimal conditions for lungs in transit
Ensures lung preservation through temperature monitoring
Provides perfusion for kidneys during transportation
Offers real-time tracking and monitoring for organ logistics
Unlock access to complete
Unlock access to complete
Funding Insights of Paragonix Technologies
Paragonix Technologies has successfully raised a total of $25.1M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $24 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $24.0M
-
First Round
First Round
(28 Dec 2011)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Series B - Paragonix Technologies | Valuation | Signet Healthcare Partners |
|
| Dec, 2013 | Amount | Seed - Paragonix Technologies | Valuation |
investors |
|
| Jul, 2012 | Amount | Grant - Paragonix Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Paragonix Technologies
Paragonix Technologies has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Getinge, HHS and Signet Healthcare Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in North America and Europe
|
Founded Year | Domain | Location | |
|
Life sciences innovation is supported through funding and programs.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Paragonix Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Paragonix Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Paragonix Technologies Comparisons
Competitors of Paragonix Technologies
Paragonix Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransMedics, OrganOx, Bridge to Life, Vascular Perfusion and ADVITOS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of organ transplantation technology
|
|
| domain | founded_year | HQ Location |
Warm storage and transport systems for harvested organs are provided.
|
|
| domain | founded_year | HQ Location |
Cold storage solutions for organ transplant preservation are provided.
|
|
| domain | founded_year | HQ Location |
Developer of a device for organ preservation
|
|
| domain | founded_year | HQ Location |
Multi-organ support systems for liver, lung, and kidney are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Paragonix Technologies
Frequently Asked Questions about Paragonix Technologies
When was Paragonix Technologies founded?
Paragonix Technologies was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is Paragonix Technologies located?
Paragonix Technologies is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Paragonix Technologies a funded company?
Paragonix Technologies is a funded company, having raised a total of $25.1M across 4 funding rounds to date. The company's 1st funding round was a Grant of $148.44K, raised on Dec 28, 2011.
What does Paragonix Technologies do?
Paragonix Technologies was founded in 2010 and is headquartered in Boston, United States. Operations center on the medical device sector, with development of systems for organ preservation and transport in transplantation. Intellectual property has been exclusively licensed from the Board of Regents of The University of Texas. Products include SherpaPak for hypothermic storage, SherpaKit integrating transport with preservation solutions, SherpaPerfusion for oxygenated perfusion, and SherpaTrak for organ tracking.
Who are the top competitors of Paragonix Technologies?
Paragonix Technologies's top competitors include TransMedics, OrganOx and ADVITOS.
What products or services does Paragonix Technologies offer?
Paragonix Technologies offers SherpaPak Cardiac Preservation, LUNGguard Organ Preservation, BAROguard Lung Preservation, KidneyVault Renal Perfusion, and Paragonix App.
Who are Paragonix Technologies's investors?
Paragonix Technologies has 4 investors. Key investors include Getinge, HHS, Signet Healthcare Partners, and Massachusetts Life Sciences Center.